Company · Scarborough, Ontario, Canada
Stcc Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 6
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 5
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| STCC-CEPHALEXIN -TAB 250MG | 02180758 | Cancelled Post Market | |
| STCC-CEPHALEXIN -TAB 500MG | 02180766 | Cancelled Post Market | |
| STCC-CEPHALEXIN 125 - ORL SUS 125MG/5ML | 02180774 | Cancelled Post Market | |
| STCC-CEPHALEXIN 250 - SUS ORL 250MG/5ML | 02180782 | Cancelled Post Market | |
| STCC-FLUOXETINE - CAP 10MG | 02155826 | Cancelled Post Market | |
| STCC-FLUOXETINE - CAP 20MG | 02155834 | Cancelled Post Market |
Notices of Compliance
Newest first.
- STCC-CEPHALEXINAugust 25, 1995 · NOC 4939 · New Drug Submission (NDS)
- STCC-CEFACLORFebruary 28, 1995 · NOC 4969 · New Drug Submission (NDS)
- STCC-FLUOXETINEFebruary 28, 1995 · NOC 5029 · New Drug Submission (NDS)
- STCC-NIZATIDINEFebruary 28, 1995 · NOC 5197 · New Drug Submission (NDS)
- STCC-NORTRIPTYLINEFebruary 28, 1995 · NOC 5198 · New Drug Submission (NDS)